- Report
- April 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- April 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- January 2025
- 175 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1419EUR$1,600USD£1,239GBP
€1774EUR$2,000USD£1,549GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1065EUR$1,200USD£929GBP
€1331EUR$1,500USD£1,162GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1065EUR$1,200USD£929GBP
€1331EUR$1,500USD£1,162GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €887EUR$1,000USD£774GBP
€1109EUR$1,250USD£968GBP
- Report
- September 2025
- 149 Pages
Global
From €2262EUR$2,549USD£1,974GBP
€2661EUR$2,999USD£2,322GBP
- Report
- June 2025
- 185 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- April 2025
- 185 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- April 2025
- 180 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- January 2025
- 182 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- January 2025
- 180 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- February 2025
- 150 Pages
Global
From €3416EUR$3,850USD£2,981GBP
€4303EUR$4,850USD£3,756GBP
- Report
- July 2025
- 350 Pages
Global
From €4391EUR$4,949USD£3,833GBP
- Report
- June 2025
- 200 Pages
Global
From €2474EUR$2,789USD£2,160GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2474EUR$2,789USD£2,160GBP
- Report
- June 2025
- 400 Pages
Global
From €4391EUR$4,949USD£3,833GBP
- Report
- June 2025
- 400 Pages
Global
From €4391EUR$4,949USD£3,833GBP

The Antihypertensive market is a subset of the Cardiovascular Drugs market, which focuses on medications used to treat high blood pressure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Antihypertensives work by blocking the action of certain hormones, such as angiotensin II, which cause blood vessels to constrict. Common classes of antihypertensives include diuretics, beta blockers, ACE inhibitors, calcium channel blockers, and angiotensin receptor blockers.
The Antihypertensive market is highly competitive, with many large pharmaceutical companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Other companies, such as AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo, also offer antihypertensive medications. Show Less Read more